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1	Introduction
According	to	estimates,	cardiovascular	diseases	are	responsible	for	17.7	millions	of	worldwide	deaths	every	year,	mainly	associated	with	heart	attacks	and	strokes	and	mostly	occurring	in	developing	countries	(Reed	et	al.,
2017;	Anderson	and	Morrow,	2017;	WHO	(World	Health	Organization),	2017WHO	(World	Health	Organization),	2017).	).	However,	early	diagnosis	of	disorders	of	heart	and	blood	vessels,	together	with	prevention	and	control	of	major	risk
factors	could	dramatically	reduce	the	steadily	increasing	mortality	rate	and	the	high	cost	from	these	adverse	events.	In	this	field,	biomarkers	detection	is	fundamental,	since	symptoms	and	electrocardiogram	changes	may	be	absent	or
nonspecific	(Babuin	and	Jaffe,	2005;	Jaffe	et	al.,	2000).	Currently,	cardiac	troponins	(I	or	T)	are	the	analytes	of	choice	for	the	detection	of	acute	myocardial	infarction.	These	proteins	confer	greater	sensitivity	and	higher	specificity	to
the	clinical	assays	with	respect	to	measurement	of	traditional	cardiac	enzymes,	such	as	creatine	kinase	and	myoglobin	(Babuin	and	Jaffe,	2005;	Jaffe	et	al.,	2000;	French	and	White,	2004).	In	this	framework,	affinity-based	biosensors
are	 particularly	 suitable	 for	 the	 development	 of	 portable	 diagnostic	 platforms	 for	 cardiac	 injury	 due	 to	mandatory	 demand	 of	 real-time	 detection	 of	 biomarkers	 with	 high	 specificity	 at	 the	 point	 of	 need	 (Sharma	 et	 al.,	 2015).
Contemporary	assays	for	troponins	detection,	for	both	commercial	and	research	purposes,	are	solely	based	on	capture	monoclonal	antibodies	with	several	constraints	linked	to	high	cost	and	low	stability	(Apple	et	al.,	2017;	Abdolrahim
et	al.,	2015;	Sheng	et	al.,	2017).	However,	in	the	last	years,	molecularly	imprinted	polymers	(MIPs)	have	emerged	as	a	robust	and	inexpensive	alternative	to	naturally	occurring	receptors.	A	number	of	MIPs	have	already	displayed
excellent	performances	in	the	selective	and	sensitive	recognition	of	small	drugs,	macromolecules,	e.g.	proteins	and	nucleic	acids,	and	microorganisms	(Mosbach	and	Ramström,	1996;	Hussain	et	al.,	2013;	Xing	et	al.,	2017;	Dabrowski
et	al.,	2018).	Several	 successful	 applications	 include	chemical	 separation	processes,	 catalysis,	 and	medical	diagnostics	 (Jetzschmann	et	 al.,	 2017;	Boysen	 et	 al.,	 2017;	Cheong	et	 al.,	 2013).	MIPs	 possess	 the	 advantage	 of	 higher
resistance	to	elevated	pressure,	temperature	and	solvent	composition	compared	to	biological	materials,	and	their	synthesis	mixture	and	conditions	are	simple	in	principle.	Dopamine	is	an	example	of	functional	monomer	used	for	self-
polymerization,	adhesion,	and	surface	coating	of	organic	and	inorganic	materials	on	the	nanometer	scale.	It	is	inspired	by	adhesive	mefp	proteins	in	mussels	that	are	rich	in	L-dopa,	with	pronounced	redox	functionality,	and	LL‐lysine-
lysine	aminoacids	(Lee	et	al.,	2007;	Liu	et	al.,	2014).	Dopamine-template	co-polymerization	creates	a	three-dimensional	network	with	cavities	complementary	to	the	original	molecule	in	terms	of	dimension,	shape,	and	noncovalent
interactions	useful	for	analyte	detection	(Mosbach	and	Ramström,	1996;	Hussain	et	al.,	2013;	Xing	et	al.,	2017).	The	main	two	strategies	for	protein	imprinting	require,	alternatively,	the	whole	biomolecule	or	small	peptide	fragments.
The	latter	 is	the	so-called	epitope	approach.	It	circumvents	the	use	of	expensive	macromolecules	and	the	difficulties	related	to	template	removal	and/or	reduced	binding	capability	frequently	encountered	with	large,	complex,	and
conformational	sensitive	proteins	(Boysen	et	al.,	2017;	Rachkov	and	Minoura,	2000,	2001).	We	present	here	an	affinity-based	biosensing	of	troponin	T	(TnT)	for	prospective	real-time	testing	of	cardiac	injury.	Literature	survey	shows
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Millions	of	premature	deaths	per	year	from	cardiovascular	diseases	represent	a	global	threat	urging	governments	to	 increase	global	 initiatives,	as	advised	by	World	Health	Organization.	In	particular,	together	with
prevention	and	management	of	risk	 factors,	 the	development	of	portable	platforms	 for	early	diagnosis	of	cardiovascular	disorders	appears	a	 fundamental	 task	 to	carry	out.	Contemporary	assays	demonstrated	very	good
accuracy	for	diagnosis	of	acute	myocardial	infarction	(AMI),	but	they	are	based	on	expensive	and	fragile	capture	antibodies.	Accordingly,	also	considering	the	massive	demand	from	developing	countries,	we	have	devoted	our
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that	very	few	experimental	studies	have	been	carried	out	on	TnT	imprinted	polymers	(Moreira	et	al.,	2011;	Karimian	et	al.,	2013,	2014;	Silva	et	al.,	2016).	In	particular,	these	previous	works	describe	the	electro-	or	initiator-dependent
polymerization	of	a	functional	monomer	in	presence	of	the	whole	TnT	protein,	and	the	subsequent	electrochemical	measurements	of	protein	binding	capability.	Differently,	we	have	used	as	recognition	element	a	biocompatible	MIP-
based	receptor	obtained	by	the	spontaneous	self-assembly	of	dopamine	in	alkaline	aqueous	media	(Lee	et	al.,	2007;	Liu	et	al.,	2014),	through	the	imprinting	of	short	(10–15	aa)	TnT-derived	peptides.	This	produces	a	self-assembling
adhesive	imprinted	nanofilm	selective	for	TnT	directly	(Fig.	1a).	Its	growth,	directly	performed	on	the	gold	sensor	surface	in	few	hours,	allows	us	to	successfully	bypass	the	formerly	reported	immobilization	of	antibodies	(Dutra	and
Kubota,	2007;	Dutra	et	al.,	2007;	Andersson	et	al.,	2010).	Thereafter,	label-free	molecular	detection	in	real-time	has	been	achieved	monitoring	the	change	in	refractive	index	at	the	MIP	film	upon	of	analyte	binding	by	using	surface
plasmon	resonance	(SPR),	one	of	the	most	validated	and	assessed	optical	techniques	(Bettazzi	et	al.,	2017).	Analysis	of	film	selectivity	has	been	performed	using	human	serum	albumin	(HSA),	which	is	the	most	abundant	protein	in
human	blood	plasma	and	serum	(Fanalia	et	al.,	2012),	instead	of	TnT.	Furthermore,	control	experiments	for	protein/surface	non-specific	interactions	have	been	made	testing	both	HSA,	TnT	on	not-imprinted	polymer	(NIP)	of	dopamine
in	place	of	MIP,	and	spiked	human	serum,	as	illustrated	in	Fig.	1b.	The	proven	efficiency	of	our	detection	method	could	pave	the	way	for	the	development	of	an	antibody-free	point-of-care	(POC)	platform	for	real-time	monitoring	of
cardiac	injury7.	Additionally,	we	have	identified	the	critical	role	of	basic	residues	of	the	epitope	for	successful	imprinting	of	peptides	and	proteins	in	PDA	through	favourable	interactions	of	amino	acid	side-chains	with	quinone	moiety.
Therefore,	 the	combination	of	 the	well-known	universal	adhesive	capability	of	PDA	 (Lee	et	al.,	2007;	Liu	et	al.,	2014)	and	 the	rational	design	of	peptides	 for	 the	PDA	 imprinting	here	described	appears	particularly	promising	 for
biosensors	research	and	application.
2	Materials	and	methods
2.1	Reagents	and	chemicals
Dopamine	hydrochloride,	tris(hydroxymethyl)aminomethane	hydrochloride	(TRIS	HCl),	sodium	hydroxide,	sodium	chloride,	magnesium	chloride,	hydrocloric	acid,	acetic	acid,	human	serum	albumin	(HSA),	and	Human	Serum
from	human	male	AB	plasma	sterile-filtered	were	purchased	from	Sigma	Aldrich	(Italy).	The	synthetic	peptides	corresponding	to	TnT	isoform	6;	also	known	as	TNT3	(The	Universal	Protein	Resource	(UniProt),(UniProt),	2017);	residues
1–10	(P-1:	MSDIEEVVEE),	50–60	(P-2:	EEAKEAEDGPM),	136–150	(P-3:	EQQRIRNEREKERQN),	and	279–288	(P-4:	GKAKVTGRWK)	were	purchased	from	Genscript	(U.S.A.).	Recombinant	human	cardiac	troponin	T	isoform	6	and	Anti-
Fig.	1	(a)	Primary	sequence	of	synthetic	peptide	analogues	of	TnT	used	as	template	for	PDA	imprinting	is	reported	with	their	approximated	distribution	along	the	TnT	protein	from	the	N-terminus	(P-1)	to	the	C-terminus	(P-4).	Positively	charged	residues	(Arg
and	Lys)	are	reported	in	blue,	whereas	the	negatively	charged	residues	(Aps	and	Glu)	are	reported	in	red.	(b)	Schematic	diagram	representation	of	gold	SPR	chip	surface	coating	with	dopamine	and	templates	(MIP),	or	dopamine	alone	(NIP)	for	the	capture
and	detection	of	analytes.
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cTnT	MAb	7G7	were	purchased	from	HyTest	Ltd.	(Finland).	All	reagents	were	used	without	further	purification.	Water	used	for	all	preparations	was	obtained	from	a	Milli-Q	system.	SPR	measurements	were	carried	out	on	Biacore	X™,
by	using	bare	gold	chips	(General	Electric	Healthcare,	Sweden).
2.2	Setup	for	surface	plasmon	resonance	measurements
Polymeric	films	of	dopamine	were	formed	on	clean	gold-coated	SPR	surface	by	applying	a	solution	of	55 g L−1	of	dopamine	in	2020 mM	TRIS	HCl	pH	8.5	at	2525 °C	on	the	device	surface	for	55 h	in	presence	(MIP),	or	in	absence
(NIP),	of	protein	TnT	(25(25 mg L−1)	or	TnT-derived	peptides	(1(1 g L−1).	Film	deposition	was	followed	by	a	washing	procedure	with	acetic	acid	(5%	v/v),	H2O,	and	running	buffer	(10(10 mM	Tris-HCl;	2020 mM	NaCl;	22 mM	MgCl2;	pH	8.3).
TnT,	HSA,	and	peptides	(10(10 μL,	from	10.0	to	0.6250.625 μg mL−1	in	the	running	buffer,	contact	time:	22 min)	were	injected	on	the	NIP	or	MIP	surfaces.	Human	serum	(20(20 μL)	and	human	serum	10%	v/v	in	PBS	pH	7.4	(100(100 μL)	were
injected	on	MIP-1234	surface.	Measurements	were	conducted	on	the	two	cells	available	(flow	rate:	55 μL min−1;	temperature:	2525 °C),	working	in	serial	mode.	The	binding	was	followed	by	a	regeneration	step	with	22 mM	sodium	dodecyl
sulphate	(SDS)	and/or	1010 mM	HCl.	Sensorgrams	were	elaborated	by	BIAevalutation	3.1	software.
3	Results	and	discussion
3.1	Evaluation	of	proteins	interaction	with	whole	protein-based	MIP
Successful	imprinting	of	TnT	protein	was	previously	achieved	by	using	acrylamides	(Moreira	et	al.,	2011),	o-phenylenediamine	(Karimian	et	al.,	2013,	2014),	and	pyrroles-carboxylic	acids	(Silva	et	al.,	2016),	as	functional	monomers.
The	reported	results	testify	that	the	stability	of	troponin	T	to	physicochemical	characteristics	of	the	environment	is	likely	due	to	its	conformational	flexibility.	In	fact,	structural	analysis	of	TnT	indicates	that	only	the	region	responsible
for	the	interaction	with	troponin	C	and	I	retains	an	α-helical	conformation	(residues	199–271),	whereas	the	N-	and	C-terminus,	through	which	the	troponin	complex	interacts	with	the	actin–tropomyosin,	appear	intrinsically	disordered
(Takeda	et	al.,	2003;	Katrukha,	2013).	In	the	present	study,	the	imprinting	efficiency	of	PDA	has	been	first	tested	on	the	entire	protein	TnT.	A	solution	of	Troponin	T	and	dopamine	has	been	left	for	5 h	onto	gold	surface	of	SPR	chip	to	form
a	 film	with	 a	 presumable	 thickness	 of	 20 nm	 in	 our	 conditions	 (Ball	 et	 al.,	 2012).	 The	 subsequent	washing	 procedure	 has	 produced	 the	MIP	 as	 biorecognition	 element	 (Fig.	 1b).	 In	 our	 experiments,	 serial	 injections	 at	 increasing
concentration	of	TnT	 solution,	 interspersed	with	a	 regeneration	 step,	 allowed	 the	 real-time	 sensing	of	protein	binding	onto	 the	 functionalized	 surface	 (MIP-TnT).	The	binding	 selectivity	 of	MIP-TnT	has	been	 tested	 repeating	 the
experiments	with	an	analogous	range	of	concentrations	of	HSA.	Moreover,	the	interaction	of	Troponin	T,	and	HSA,	with	NIP	has	been	also	investigated	to	take	into	account	the	non-specific	interaction	of	proteins	of	interest	with	the
non-imprinted	film	of	polydopamine.	Fig.	2	displays	the	response	of	the	SPR	chips	to	increasing	TnT	and	HSA	concentrations	injected	onto	MIP	(a)	and	NIP	(b)	surfaces	in	the	range	of	0–289 nM,	exhibiting	a	fast	(2 min)	binding	of	TnT
with	MIP	(Fig.	2a),	with	larger	amount	of	TnT	bound	on	MIP	(b)	in	comparison	with	TnT	on	NIP	(c),	as	well	as	the	negligible	interaction	of	HSA	with	MIP	or	NIP	(b,	c).	The	change	in	slope	at	the	end	of	the	analyte	injections	around
150 s	in	Fig.	2a	is	due	to	the	running	buffer	after	the	end	of	analyte	injection.	The	high	stability	of	the	signal	during	the	washing	stage	demonstrates	the	excellent	stability	of	the	affinity	complex.	Moreover,	Fig.	2d	indicates	that	the
biosensor	responds	linearly	to	the	TnT	concentrations	in	the	range	here	explored	with	a	sensitivity	of	2.64	RU nM−1.	The	estimated	limit	of	detection	(LoD)	is	15.4 nM,	and	was	inferred	by	the	lowest	TnT	concentration	giving	a	signal
greater	 than	 three	 times	 the	 standard	deviation	of	 the	noise	 level	 of	 baseline	 in	buffer	 (3σ	=	15	RU).	Conversely,	 the	 interaction	 signals	 of	HSA	with	MIP	are	 small,	 almost	 irrespective	 of	 concentration	 of	 protein	 injected,	 and
comparable	to	the	responses	diagrams	from	NIP.	Altogether	these	results	confirm	the	effective	imprinting	of	TnT	protein	on	PDA.	Increasing	standard	deviations	appear	for	high	analyte	concentration	(Fig.	2a).	This	signal	variability	is
likely	due	to	non-specific	binding	with	polydopamine	film	in	presence	of	large	TnT	excess.	This	effect	is	confirmed	by	the	consequent	difficulty	in	achieving	the	complete	analyte	removal	during	the	regeneration	step.	In	fact,	a	similar
behavior	is	displayed	by	the	NIP	surface	for	the	same	analyte	concentration	(Fig.	2c).	However,	this	drawback	seems	not	so	limiting	considering	the	perspective	of	a	disposable	POC	test	for	TnT	at	low	concentration	through	a	signal
amplification	strategy	(Lisi	et	al.,	2017;	O’Connor	et	al.,	2016).
3.2	Rational	selection	of	peptide	fragments	and	analysis	of	TnT	Epitope-imprinting
Although	useful	dopamine-based	MIP	has	been	here	achieved	and	the	use	of	capture-antibodies	has	been	conveniently	avoided,	the	whole	protein	here	and	previously	exploited	for	surface	imprinting	still	confers	high	cost	to
this	strategy21‐2421–24.	In	this	regard,	the	so-called	epitope-imprinting	has	emerged	as	a	favourable	approach	to	circumvent	the	use	of	expensive	macromolecules	for	analyte	detection	(Rachkov	and	Minoura,	2001).	This	method	requires	the
identification	of	small	and	surface-exposed	peptide	fragments	(epitopes)	of	the	protein	used	as	templates	for	MIP	preparation.	However,	to	the	best	of	our	knowledge,	this	approach	has	been	never	used	for	TnT.	The	rational	selection	of
our	templates	is	based	on	the	analysis	of	structural	data	and	binding	sites	of	commercially	available	antibodies	for	TnT.	In	detail,	we	have	tested	four	short	peptides	corresponding	to	conformationally	flexible	and	solvent	exposed
regions	of	TnT.	In	particular,	they	are	analogous	to	the	N-terminus	(P-1),	the	C-terminus	(P-4),	and	two	epitopes	recognized	by	commercially	available	TnT	antibodies,	namely	7G7	and	1C11,	corresponding	to	peptides	P-2	and	P-3,
respectively	(Fig.	1a).	Similarly	 to	TnT-based	MIP	preparation,	we	have	 imprinted	 the	above	 reported	peptides	 in	a	 film	of	PDA	by	using	a	 solution	containing	 the	 templates	altogether	at	equal	concentrations	 instead	of	TnT,	and
following	the	procedure	already	described	for	imprinting	and	templates	removal	(Fig.	1b).	The	SPR	chip	imprinted	with	four	peptides	(MIP-1234)	has	been	evaluated	for	TnT	and	HSA	binding	efficiency,	and	the	response	diagrams	for
the	TnT	and	HSA	injections	are	reported	in	Fig.	3.	Notwithstanding	the	reduced	size	and	complexity	of	the	epitopes	in	comparison	to	whole	protein,	MIP-1234	biosensor	retains	the	linear	response	to	the	troponin	concentrations	here
observed	for	MIP-TnT,	with	even	larger	sensitivity	of	3.15	RU	nMRU nM−1,	lower	LoD	(14.8(14.8 nM)	and	lesser	non-specific	interaction	with	HSA.	These	remarkable	results	for	epitope-imprinting	of	TnT	protein	are	unprecedented	and
move	us	closer	to	achieving	the	original	intent,	i.e.	the	development	of	affordable	real-time	antibody-free	testing	for	cardiac	injury.
Fig.	2	(a)	Representative	sensograms	for	injections	of	TnT	and	HSA	on	MIP-TnT.	Slope	change	indicates	the	end	of	TnT	injection,	i.e.	complex	stability	in	running	buffer.	(b)	MIP-TnT	and	(c)	NIP	response	of	SPR	biosensors	at	different	concentrations	of	TnT	and	HSA.	(c)	Linear	fitting
of	MIP	response	to	TnT	and	HSA	injections.	We	have	analyzed	four	replicates	for	each	analyte	concentration,	intersperse	with	a	regeneration	step,	and	reported	the	mean	value	and	the	standard	deviation	as	error	bars.
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3.3	Investigation	of	MIP	based	on	single	TnT-epitope
Following	the	achievement	described	above,	we	have	decided	to	look	closer	to	this	successful	design,	exploring	the	role	of	each	epitope	in	template	formation	and	consequent	binding	efficacy	of	MIP.	Accordingly,	we	have	tested
the	affinity	 of	MIP-1234	described	above	 for	 single	 synthetic	peptide	 injected	 singularly	on	 the	 sensor	 chip.	Surprisingly,	 only	P-4,	 corresponding	 to	TnT	C-terminus,	 appears	 to	 interact	with	both	 the	 imprinted	 surface	and	non-
imprinted	surfaces.	Conversely,	the	other	peptides	have	given	negligible	signals	on	MIP	and	NIP	(Fig.	S1).	These	results	might	indicate	that	only	P-4	has	been	correctly	imprinted	with	PDA,	therefore	allowing	the	capture	of	TnT,	and
suggesting	that	the	imprinting	of	P1,	P2	and	P3	does	not	improve	the	sensitivity	and	specificity	of	our	MIP-1234	with	respect	to	MIP-4	here	tested,	and	also	likely	the	performance	of	MIP-14,	MIP-24,	and	MIP-34	would	be	all	very
similar.	Tentatively,	we	ascribe	this	outcome	to	the	peculiar	 features	of	TnT	C-terminus	 in	terms	of	higher	conformational	mobility	and	 larger	basicity	(P-4,	pI	=	11.8)	 in	comparison	to	the	other	protein	epitopes	here	explored.	 In
particular,	the	molecular	constraints	of	the	inner	regions	of	TnT	could	represent	an	obstacle	to	properly	match	the	shape	left	by	the	linear	peptides	P-2	and	P-3.	Moreover,	although	the	N-terminal	region	should	not	suffer	from	this
drawback,	the	highly	acid	character	of	this	peptide	(P-1,	pI	=	2.89)	could	be	unfavourable	for	the	imprinting	in	dopamine	polymer.	The	same	for	the	subsequent	rebinding,	because	of	the	electrostatic	repulsion	with	the	negatively
charged	PDA	(Ma	et	al.,	2015).	In	fact,	P-4	is	positively	charged	in	the	experimental	conditions	of	surface	imprinting.	As	previously	showed	for	other	proteins	and	peptides	(Burzio	and	Waite,	2000;	Wang	et	al.,	1996),	MIP	formation	could	be
thus	also	favoured	by	reversible	nucleophile	attack	of	lysine	residues	to	quinones	moiety	of	PDA,	which	are	abundant	in	P-4	and	absent	in	P-1.	Finally,	in	order	to	exclude	eventual	hindrance	among	peptides	in	solution	during	MIP-1234
formation,	we	decided	to	produce	a	MIP	surface	for	each	epitope.	Again,	Troponin	T	is	able	to	selectively	and	specifically	bind	only	to	MIP-4	(Fig.	4).	Moreover,	the	MIP	surface	generated	by	using	P-4	as	template	reproduces	the
sensitivity	already	observed	for	MIP-TnT	and	MIP-1234	(3.15	RU	nMRU nM−1)	in	response	to	TnT	injections	although	with	a	little	higher	LoD	(41.0(41.0 nM).	Conversely,	MIP-1,	MIP-2,	and	MIP-3	give	signals	almost	indistinguishable	from
NIP	(Fig.	S2).
Fig.	3	(a)	Response	of	MIP-1234	SPR	biosensor	at	different	concentrations	of	TnT	and	HSA.	(b)	Linear	fitting	of	MIP	response	to	TnT	and	HSA	injections.	We	have	analyzed	four	replicates	for	each	analyte	concentration,	intersperse	with	a	regeneration	step,	and	reported	the	mean
value	and	the	standard	deviation	as	error	bars.
alt-text:	Fig.	3
Fig.	4	(a)	Response	of	MIP-4	SPR	biosensor	at	different	concentrations	of	TnT	and	HSA.	(b)	Linear	fitting	of	MIP	response	to	TnT	and	HSA	injections.	We	have	analyzed	four	replicates	for	each	analyte	concentration,	intersperse	with	a	regeneration	step,	and	reported	the	mean	value
3.4	TnT	detection	from	spiked	human	serum
Finally,	we	have	tested	sterile-filtered	human	sera	samples	injected	on	MIP-1234	biosensor,	with	and	without	the	addition	of	TnT	at	the	highest	concentration	of	analyte	here	investigated.	The	response	obtained	from	SPR	was
the	same	for	pure	human	serum	and	samples	spiked	with	TnT	because	of	not-specific	adsorption	of	molecules	from	this	complex	biological	matrix	(data	not	shown).	However,	the	subsequent	injection	of	a	TnT-specific	antibody	(7G7
clone)	has	clearly	and	selectively	recognized	the	target	analyte,	as	shown	in	Fig.	5.	This	was	successfully	achieved	both	on	10%	and	undiluted	serum.	Furthermore,	the	surface	of	the	coated	sensor	chip	has	been	regenerated	after	each
experiment,	confirming	the	stability	and	reusability	of	the	MIP	surface.	However,	due	to	the	complexity	of	the	real	matrix,	a	dedicated	regeneration	protocol	has	been	performed,	consisting	in	22 mM	SDS	followed	by	1010 mM	HCl,	and
deserves	further	improvement.	However,	for	the	perspective	application	of	the	method	to	point-of-care	testing,	regeneration	aspects	of	this	kind	of	low	cost	and	biomimetic	receptors	result	of	minor	importance	respect	to	sensitivity	and
selectivity.	Ongoing	work	is	dedicated	to	the	amplification	of	the	detection	limit	by	substituting	the	7G7	antibody	with	a	secondary	synthetic	receptor.
4	Conclusions
We	have	described	here	the	first	example	of	epitope-imprinted	biosensor	for	cardiac	biomarker	troponin	T	(TnT),	which	is	released	from	the	cardiac	tissue	in	the	blood	stream	upon	the	damage	of	myocytes	(French	and	White,
2004;	Möckel	et	al.,	2004).	Contemporary	assays	are	all	based	on	monoclonal	antibodies,	and	the	clinical	ones	are	specific	to	protein	residues	in	the	middle	of	the	primary	sequence	for	capture	and	detection	of	TnT.	Conversely,	we	have
developed	here	a	stable	and	inexpensive	polydopamine	film	imprinted	with	TnT-epitope,	which	exhibits	a	fast	and	specific	capture	of	protein	through	its	C-terminal	region	that,	advantageously,	should	not	be	affected	by	proteolytic
degradation	of	TnT	recently	detailed		in	vivoin	vivo	(Cardinaels	et	al.,	2013;	Katrukha	et	al.,	2017).	Moreover,	 it	 leaves	all	the	remaining	part	of	protein	available	for	molecular	interactions	with	any	specific	antibody.	The	adhesive
property	of	mussel	foot	proteins	due	to	the	recurrence	of	both	L-dopa	finds	strict	analogy	with	the	same	catechol	functionality	of	dopamine,	and	basic	residues	media	(Lee	et	al.,	2007,	2011;	Liu	et	al.,	2014),	and	help	us	to	advance
some	considerations.	We	hence	attribute	the	effectiveness	of	TnT	C-terminus	in	producing	the	imprinted	film	to	the	concurrence	of	flexibility	and	basicity	of	this	template,	characteristics	also	found	in	another	peptide	previously	used
for	epitope	 imprinting	of	PDA	 for	gp41	detection	 (Lu	et	al.,	2012).	Therefore,	 interconnected	 features	of	 template,	 such	as	 length,	hydrophilicity,	 flexibility	 and	uniqueness,	 as	elsewhere	described	 for	 the	 imprinting	of	 acrylates
polymers	(Bossi	et	al.,	2012)	play	undoubtedly	a	key	role.	Further,	the	presence	of	basic	side-chains,	which	favour	electrostatic	and	nucleophilic	interactions	with	quinone	moieties	of	PDA,	appear	equally	crucial	for	rational	selection	of
peptides	for	molecular	imprinting	onto	dopamine	polymers.	This	therefore	may	extend	the	field	of	application	of	this	methodology	well	beyond	the	analytes	and	the	sensory	surface	here	investigated.	Our	MIP-based	biosensor	gives	a
linear	SPR-response	to	the	troponin	concentration	in	the	nanomolar	range	with	a	good	sensitivity,	however	these	values	are	above	the	picomolar	level	found	for	TnT	in	blood	(French	and	White,	2004;	O’Connor	et	al.,	2016;	Westermann
et	al.,	2017).	However,	 the	necessity	 to	detect	much	 lower	Troponin	T	concentration	should	overcome	the	disadvantageous	 increase	of	standard	deviation	encountered	here	 for	 the	highest	analyte	concentration,	 likely	due	 to	 the
increased	non-specific	binding	of	TnT	with	PDA.	Nevertheless,	as	demonstrated	by	our	preliminary	experiments	in	spiked	human	serum,	through	a	signal	amplification	strategy,	and	independently	of	transduction	technique,	this	new
and	the	standard	deviation	as	error	bars.
alt-text:	Fig.	4
Fig.	5	Response	of	MIP-1234	SPR	biosensor	at	2323 mg L−1	of	Anti-TnT	7G7	MAb	after	surface	adsorption	of	human	serum	and	human	serum	spiked	with	TnT	at	289289 nM.	The	experiments	have	been	repeated	with	serum	diluted	at	10%	v/v	in	running	buffer.	We	have	analyzed	four
replicates	for	each	analyte	concentration,	intersperse	with	a	regeneration	step,	and	reported	the	mean	value	and	the	standard	deviation	as	error	bars.
alt-text:	Fig.	5
capture	method	for	TnT	opens	the	door	to	affordable	real-time	testing	for	cardiac	injury	at	the	point	of	need.	Ongoing	work	is	dedicated	to	the	amplification	of	the	detection	limit	by	using	molecular	architectures	built	in	a	layer-by-layer
fashion,	biomolecules	and	nanostructures,	as	also	recently	reported	(Lisi	et	al.,	2017;	O’Connor	et	al.,	2016).	Uncited	references(Uniprot;	Who)
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Highlights
• Troponin	T	is	the	most	sensitive	and	selective	biomarker	of	acute	myocardial	infarctioninfarction.
• Emergency	and	clinical	tests	for	TnT	are	still	based	on	immuno-reactions	and	antibodiesantibodies.
• Here	the	first	TnT	biosensor	based	on	epitope	imprinting	on	polydopamine	is	presentedpresented.
• Epitope	imprinting	with	short	peptides	from	TnT	allowed	low-cost	and	fast	preparationpreparation.
• Direct	assays	in	standard	solutions	and	sandwich	assays	on	spiked	serum	are	reportedreported.
